Peer reviewed by medical experts that included three U.S. government senior scientists and published in the American Journal of Therapeutics, the research (Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19) is the most comprehensive review of the available data taken from clinical, in vitro, animal, and real-world studies.
Led by the Front Line COVID-19 Critical Care Alliance (FLCCC), a group of medical and scientific experts reviewed published peer-reviewed studies, manuscripts, expert meta-analyses, and epidemiological analyses of regions with Ivermectin distribution efforts all showing that Ivermectin is an effective prophylaxis and treatment for COVID-19.
A focus of the manuscript was on the 27 controlled trials available in January 2021, 15 of which were randomized controlled trials (RCT's), the preferred trial of the World Health Organization (WHO), U.S. National Institutes of Health (NIH), and the European Medicines Agency.
Consistent with numerous meta-analyses of Ivermectin RCT's since published by expert panels from,
...they found large,
statistically significant reduction in mortality, time to recovery
and viral clearance in COVID-19 patients treated with Ivermectin.
The results as seen in this latest study demonstrate that the Ivermectin distribution campaigns repeatedly led to,
The published research (Emerging Evidence Demonstrating the Efficacy of Ivermectin in
the Prophylaxis and Treatment of COVID-19) can be found
in the latest edition of the American Journal of Therapeutics.